Cogent Biosciences, Inc. COGT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s enterprise value?
- Cogent Biosciences, Inc. (COGT) reported enterprise value of $6.02B in Q1 2026.
- How has Cogent Biosciences, Inc.'s enterprise value changed year-over-year?
- Cogent Biosciences, Inc.'s enterprise value increased by 950.8% year-over-year, from $573.05M to $6.02B.
- What is the long-term trend for Cogent Biosciences, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s enterprise value has grown at a 89.6% compound annual growth rate (CAGR), from $210.54M to $5.16B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.